LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study (LIVE)
Sponsor: AstraZeneca
A observational or N/A phase clinical study on COVID-19, SARS-CoV-2, this trial is completed. The trial is conducted by AstraZeneca and has accumulated 15 data snapshots since 2022. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
15 versions recorded-
Nov 2025 — Present [monthly]
Completed
-
Sep 2025 — Nov 2025 [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
May 2024 — Jul 2024 [monthly]
Completed
▶ Show 10 earlier versions
-
Jun 2023 — May 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2023 — Jun 2023 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Feb 2023 — Mar 2023 [monthly]
Recruiting
-
Dec 2022 — Feb 2023 [monthly]
Recruiting
-
Oct 2022 — Dec 2022 [monthly]
Recruiting
-
Sep 2022 — Oct 2022 [monthly]
Recruiting
-
Jul 2022 — Sep 2022 [monthly]
Recruiting
-
Jun 2022 — Jul 2022 [monthly]
Recruiting
-
May 2022 — Jun 2022 [monthly]
Recruiting
-
Apr 2022 — May 2022 [monthly]
Recruiting
First recorded
Feb 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- AstraZeneca
For direct contact, visit the study record on ClinicalTrials.gov .